Literature DB >> 23801239

Small intestinal lymphoma in a post-renal transplant patient: a rare case with late presentation.

Ritesh Kumar1, Divya Khosla, Rakesh Kapoor, Shreekant Bharti.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 23801239     DOI： 10.1007/s12029-013-9517-3

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  24 in total

Review 1.  Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines.

Authors:  Anne Parker; Kristin Bowles; J Andrew Bradley; Vincent Emery; Carrie Featherstone; Girish Gupte; Robert Marcus; Jayan Parameshwar; Alan Ramsay; Charles Newstead
Journal:  Br J Haematol       Date:  2010-04-16       Impact factor: 6.998

2.  Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders.

Authors:  V Leblond; N Dhedin; M F Mamzer Bruneel; S Choquet; O Hermine; R Porcher; S Nguyen Quoc; F Davi; F Charlotte; R Dorent; B Barrou; J P Vernant; M Raphael; V Levy
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

Review 3.  Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

Authors:  Deepa Jagadeesh; Bruce A Woda; Jacqueline Draper; Andrew M Evens
Journal:  Curr Treat Options Oncol       Date:  2012-03

Review 4.  Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.

Authors:  C V Paya; J J Fung; M A Nalesnik; E Kieff; M Green; G Gores; T M Habermann; P H Wiesner; J L Swinnen; E S Woodle; J S Bromberg
Journal:  Transplantation       Date:  1999-11-27       Impact factor: 4.939

5.  Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.

Authors:  M F Mamzer-Bruneel; C Lomé; E Morelon; V Levy; P Bourquelot; F Jacobs; A Gessain; E Mac Intyre; N Brousse; H Kreis; O Hermine
Journal:  J Clin Oncol       Date:  2000-11-01       Impact factor: 44.544

Review 6.  The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.

Authors:  M Green; J Reyes; S Webber; D Rowe
Journal:  Transpl Infect Dis       Date:  2001-06       Impact factor: 2.228

7.  Identification of prognostic factors in post-transplant lymphoproliferative disorders.

Authors:  Sylvain Choquet; Bruneel Marie-France Mamzer; Olivier Hermine; Raphaël Porcher; Quoc Stephanie Nguyen; Frederic Davi; Frédéric Charlotte; Richard Dorent; Benoit Barrou; Jean-Paul Vernant; Martine Raphael; Vincent Levy; Véronique Leblond
Journal:  Recent Results Cancer Res       Date:  2002

Review 8.  Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients.

Authors:  J K Preiksaitis; S Keay
Journal:  Clin Infect Dis       Date:  2001-07-01       Impact factor: 9.079

9.  Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants.

Authors:  C L Davis; B L Wood; D E Sabath; J S Joseph; C Stehman-Breen; V C Broudy
Journal:  Transplantation       Date:  1998-12-27       Impact factor: 4.939

10.  Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.

Authors:  Sylvain Choquet; Stephan Oertel; Veronique LeBlond; Hanno Riess; Nathalie Varoqueaux; Bernd Dörken; Ralf Trappe
Journal:  Ann Hematol       Date:  2007-05-24       Impact factor: 3.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.